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A highly diverse T-cell receptor (TCR) repertoire is a fundamental property of
an effective immune system, and is associated with efficient control of viral
infections and other pathogens. However, direct measurement of total TCR
diversity is impossible. The diversity is high and the frequency distribution of
individual TCRs is heavily skewed; the diversity therefore cannot be captured
in a blood sample. Consequently, estimators of the total number of TCR clono-
types that are present in the individual, in addition to those observed, are
essential. This is analogous to the ‘unseen species problem’ in ecology. We
review the diversity (species richness) estimators that have been applied to
T-cell repertoires and the methods used to validate these estimators. We show
that existing approaches have significant shortcomings, and frequently under-
estimate true TCR diversity. We highlight our recently developed estimator,
DivE, which can accurately estimate diversity across a range of immunological
and biological systems.1. Introduction
The human T-cell receptor (TCR) repertoire—the range of different TCRs
expressed—plays a vital role in host defence. By recombination, random insertion,
deletion and substitution, the small set of genes that encode the T-cell receptor has
the potential to create between 1015 and 1020 TCR clonotypes (a clonotype is a
population of T cells that carry an identical TCR) [1,2]. However, the actual diver-
sity of a person’s TCR repertoire cannot possibly lie in this range. There are only an
estimated 1013 cells in the human body [3], andmany clonotypes are of high abun-
dance due to strong selection forces (for example, thymic education or antigen
specificity). The actual, or realized, diversity of the human TCR repertoire remains
unknown. The term ‘diversity’ is commonly used to mean either the number of
classes (also known as ‘species richness’), or the degree of dispersion among
those classes. In this study, we use the term ‘species’ to refer to a single TCR
clonotype, and ‘diversity’ to refer to the number of TCR clonotypes.
TCRs are heterodimers and fall into two classes: TCR-ab andTCR-gd; gdT cells
constitute 1–10%of the T-cell repertoire [4].Avariable (V ), joining (J ) and constant
region (C) constitute the TCR a- and g-chains. The TCR b- and d-chains are also
madeupof aV, J andC region,with an additional diversity (D) region [5]. One seg-
ment fromeach region is recombined,with additional nucleotide additions and/or
deletions, togenerate each rearrangedTCR (figure 1). This recombinationgenerates
high T-cell diversity [1] and enables the recognition of millions of antigens [6].
While V(D)J gene rearrangement is believed to be random [7], some clonotypes
are produced more commonly than others [2,8], leading to unequal frequencies
of naive T-cell clonotypes and to ‘public’ clonotypes, i.e. clonotypes shared
between people. This unequal frequency distribution is believed to be due to a
process known as convergent recombination, whereby certain nucleotide
sequences can be produced using a greater variety of recombination events; cer-
tain amino acid sequences can bemade by a greater number of nucleotide triplets;
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Figure 1. T-cell receptor gene rearrangement. (a) Variable (V ), joining (J ) and constant regions (C ) constitute the TCR a-chain. (b) Variable (V ), joining (J ) and
constant regions (C ) constitute the TCR b-chain, with an additional diversity (D) region. Segments from each region are recombined, with additional nucleotide
additions, to generate each rearranged TCR. These processes generate substantial T cell diversity. (c,d) Hypervariable complementarity-determining regions (CDR1-
CDR3) of the a-chain (c) and b-chain (d ). CDR1 and CDR2 regions are encoded on the V region, while the most variable CDR3 region straddles the V(D)J junction.
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or substitutions [9].
The third complementarity-determining region 3 (CDR3)
of both the TCR a- and TCR b-chains straddles the V(D)J
junction [10,11] (figure 1b), the primary site of antigen contact
[5]. The CDR3 is the region most affected by recombination
[12], and the CDR3 region of the b-chain accounts for most
of the variation within a person’s T-cell repertoire. Antigenic
cross-reactivity of T cells results in a discrepancy between
structural diversity (the number of different nucleotide or
amino acid TCR combinations in the host) and functional
diversity (the number of different antigens recognized by
the T-cell repertoire) [1].2. Why is T-cell receptor diversity important?
TCR diversity is associated with the effective control of viral
infections and other pathogens [13–15]. The number of clono-
types observed in the blood in one person has been reported to
decreasewith age [16–19], viral challenge [15,20,21], immuniz-
ation [22] and as a result of immune suppression, for example
after haematopoietic stem cell transplantation (HSCT) [23].
TCR diversity has also been positively associated with autoim-
munity in both mice [24,25] and humans [26]. Accurate
quantification of diversity is important to assess the extent of
immune convergence (sharing of clonotypes between people)
[7,24,27–29].
Species diversity is also important in many systems out-
side T-cell immunology, for example, in estimating the
repertoire of antibody classes [30,31], assessing the size of
the metagenome in microbial communities [32,33] and
measuring the rate of evolution of quasi-species of a patho-
genic virus [34]. The original motivation for estimating
diversity comes from population ecology, where the question
of how many species there are in a given population gives
rise to the ‘unseen species problem’: how many species are
present, but unobserved, in the population of interest? Typi-
cally, there is a nonlinear relationship between the number ofindividuals (e.g. a T cell, a microbe) and the number of
‘species’ (e.g. a clonotype or viral variant), and so diversity
cannot usually be estimated through linear scaling.3. Why is estimating diversity difficult?
Estimating the diversity of the T-cell repertoire is difficult for
many reasons. First, the repertoire is highly diverse. Given
the number of T cells, (assumed to be of the order of 1012
[35,36]), a diversity of (say) 107 clonotypes [36] is unlikely to
be directly observed owing to the limited volume of blood
that can be taken from a person at any one time, and to the
heavy-tailed frequency distributions with highly non-uniform
clonotype abundances [19,37].
Second, the precise relationship between the diversity of
different TCR-a and TCR-b sequences and the actual TCR
functional diversity is unclear. Most recent studies focus on
the CDR3 region [5,24,38–40], because it is the most variable
region and because it is short enough to be captured in a
single sequence read [30]. However, a T-cell receptor consists
of pairings between either a and b chains or g and d chains;
this adds a further level of diversity that is not routinely
captured by many sequencing approaches. Furthermore, the
relationship between TCR sequence and three-dimensional
structural diversity and functional diversity are not fully
understood [40,41].
Third, laboratory techniques that give absolute and
unbiased estimates of clonotype frequency are technically
challenging. Early studies measured TCR diversity qualitat-
ively, where different clonotypes were identified visually as
discrete bands on genomic southern blots [42–44]. Other
approaches [45] used flow cytometry to measure the average
observed frequency of each clonotype, reasoning that if this
frequency was low then the population was more diverse.
Greater precision was achieved with spectratyping
[22,46,47], where the number of different CDR3 lengths is
used as a proxy for the number of clonotypes. The degree to
which the frequency distribution of CDR3 lengths deviates
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Figure 2. PCR amplification can lead to ‘false saturation’ of rarefaction curves.
Example of ‘exhaustive sequencing’ of CD4þ T cell compartment in a healthy
donor. Unbiased sequence data was obtained through 50 rapid amplification
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of reduced diversity (because of limited lymphocyte capacity)
[21,26]. Although this inference seems reasonable, expansion
of some clonotypes does not imply the extinction of other
clonotypes, merely their reduced relative frequency. Spectra-
typing produces incomplete sequence information [10]
without further subcloning of the PCR product [2,48,49]
which is low-throughput and labour-intensive [26,40].
High-throughput sequencing (HTS) allows greater sequen-
cing depth and significantly more accurate quantification of
TCR clonotype abundance [39], albeit at a greater expense
than spectratyping [10]. However, HTS is still subject to
PCR bias and sequencing error, with the consequences that
clonotype abundances can be drastically distorted and that
non-existent clonotypes can be recorded, thus falsely increasing
the observed diversity [50].of cDNA ends (RACE) [53]. The rarefaction curve approaches saturation, falsely
implying that further sequencing would not yield many additional clono-
types. However, the approximate saturation value of 2.5  104 is not a
realistic estimate of total CD4þ TCR diversity. For example, Robins et al.
[47] frequently observed more than 105 clonotypes before estimating the
number of unseen clonotypes. PCR amplification overestimates the repeated
observation of TCR clonotype in the sample, leading to false saturation and
substantial underestimates of TCR diversity. (Online version in colour.)
.B
370:201402914. Unbiased sequencing of T-cell receptor
diversity is insufficient for diversity estimation
50 rapid amplification of cDNA ends (RACE) is reported to
suffer from markedly less bias than other HTS approaches
[5,51]. Nevertheless, 50 RACE (and unbiased sequencing
more generally) is unlikely to be sufficient for diversity esti-
mation. Diversity estimation usually makes use of two
quantities: the relative abundances of observed species, and
the extent to which each species is repeatedly observed in the
sample. If PCR amplification is unbiased, then relative abun-
dances will be preserved but the degree of repetition in the
sample will not.5. ‘Exhaustive sequencing’ cannot capture full
repertoire diversity
Because all T cells within a sample of blood will not usually
be detected in a single sequencing experiment, many
researchers have used ‘exhaustive sequencing’ [37,38,52], i.e.
the library is sequenced with the greatest possible depth, to
maximize the number of reads per clonotype. It can then be
justifiably concluded that further sequencing of the same
library would not yield greater observed diversity. It is there-
fore tempting to conclude that the sample of blood contains a
complete census of clonotypes in the periphery. However,
such a conclusion would be false.
The principle that exhaustive sequencing does not capture
full repertoire diversity was demonstrated by Warren et al.
[52]. The authors exhaustively sequenced a library derived
from a peripheral blood sample. However, upon sequencing
a second library derived from the same blood sample, they
found that 75% of the sequences returned were new, i.e. not
contained in the first library. Furthermore, sequencing data
were obtained from a second independent blood sample,
and only 13% of the clonotypes observed in the second
sample were observed in the first. This indicates that exhaus-
tive sequencing of a single sample is incapable of capturing
diversity, regardless of the apparent degree of repetition of
species provided. That is, a saturating relationship between
the number of reads and the number of clonotypes does not
imply that there is a saturating relationship between the
number of T cells and the number of clonotypes. The limit-
ing factor is the number of TCRs present in the sample, notthe extent of amplification or depth of sequencing. We have
observed similar effects of ‘false repetition’ and ‘false saturation’
in our work [53]: figure 2 shows apparent saturation of the
number of new clonotypes observed as the number of sequence
reads increases. However, the number of clonotypes in the full
data (2.5 104) is a drastic underestimate of TCR diversity,
where between 105 and 106 distinct CDR3 sequences have
been directly observed [47,52]. Finally, it has been noted [54]
that exhaustive sequencing of either or both of the TCR a and
b chains is insufficient to capture the full repertoire of a person.6. Absolute T-cell counts are required
for diversity estimation
Recent approaches have used DNA barcoding [29,50,51,55]
or amplicon length discrimination [56,57] to resolve the
problems of PCR amplification. Under DNA barcoding, a clo-
notype is identified by its nucleotide or amino acid sequence,
but a second identifier is assigned to each individual short
DNA sequence through the addition of a random DNA
sequence label. Thus, the combination of a given clono-
type nucleotide sequence and a given random label is
unique. This allows identical T cells to be distinguished
from identical sequence reads, and so preferential amplifica-
tion is irrelevant. For example, if there are two amplicons
that have identical CDR3 sequences and identical labels, it
can be concluded that both amplicons have been derived
from a single DNA sequence. The resulting data therefore
consist of absolute—not relative—clonotype abundances,
which are required for any abundance-based estimator. Fur-
thermore, DNA barcoding can be extended to correct for
sequencing error [50,55].
Another factor that prevents absolute quantification of TCR
abundance is the sequencing of cDNA rather than genomic
DNA, since a single T cell may express multiple mRNA
copies. Therefore, cDNA is not suitable for diversity estimation.
Table 1. Comparison of diversity estimation approaches.
estimator advantages disadvantages
parametric
(e.g. Poisson abundance
models, Power laws)
can estimate clonotype frequency distribution requires a priori assumptions on analytical form of
clonotype frequency distribution
lack of validation: goodness-of-ﬁt to observed data
does not conﬁrm model accuracy
non-parametric abundance-
based estimators
(e.g. Chao1, ACE, capture–
recapture)
no a priori assumptions required on analytical form
of clonotype frequency distribution
cannot estimate clonotype frequency distribution
biased by sample size
inaccurate in highly diverse immunological
populations
non-parametric incidence-based
estimators
(e.g. Chao2, ICE)
does not require absolute count data lack of validation in immunological populations
biased by sample size
DivE accurate in multiple validations, across all
immunological populations tested
unbiased by sample size
time consuming: multiple models must be ﬁtted
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Even where data collection involves considerable sequencing
depth, andwhere unbiased data have been obtained, estimators
of the number of unseen clonotypes will need to be employed
because of limits on blood volume that can be taken from
donors. Several estimators of species richness (i.e. the number
of species) developed in ecology have been applied to estimate
TCR diversity, treating each clonotype as a ‘species’. Such esti-
mators fall into two broad categories: parametric estimators
[58], where the shape of the species frequency distribution is
assumed to follow some analytical form, and non-parametric
estimators thatmake no such assumptions, and thus population
frequencies cannot be inferred [59]. Since the true numbers of
species or clonotypes are unknown, it is difficult to validate
estimators of diversity, and so in common with ecological
populations, it is often unclear which estimator should be
used. We compare diversity estimators below and in table 1.8. Differences between ecological and
immunological data
There are important qualitative differences between T-cell
repertoires and ecological populations in the uniformity of
sampling. In ecological populations, data collection is fre-
quently not random. For example, while placement of
quadrats may be random, all of the individuals present in
that quadrat are counted, leading to clustering of data [60].
Also, the probability of detection varies between species as it
is influenced by colour, physical size, noise emission, geo-
graphical distribution, movement, variety of habitats and
relationship to other species [61,62]. By contrast, in samples
of T cells derived from blood, it is reasonable to assume that
individual T cells have the same probability of detection; this
assumption is less justifiable in solid tissue, as for example,
lesions are non-randomly sampled.
In many ecological populations (e.g. plants, arthropods),
the actual counting of individuals present in the sample ismore straightforward than for populations of T cells, where
sequencing introduces biases [19] and where it is difficult
to distinguish sequencing errors from rare species [52]. The
frequent implicit assumption that sequencing data comprised
individuals that are equally detectable is often inappropriate.
The probability that a given sequence read is recorded is con-
ditional on two events: first, the probability that the T cell is
sampled from blood, which is equal among T cells; and
second, the probability that an amplicon from a T cell is
amplified, which is not equal across all CDR3 sequences.
This problem does not arise in ecological datasets.
The use of diversity indices developed in ecology that are
used in T-cell repertoires is not restricted to species richness
estimators. Similarity indices such as the Jaccard [63,64],
Morisita-Horn [41,63], analysis of similarity (ANOSIM) [10]
and dispersion metrics such as Simpson’s diversity index
[48,65], the Shannon entropy [20,66] and Renyi entropy [66]
have been used to compare the TCR diversities between
different people or between different T-cell phenotypes
[65,67]. Many of the difficulties that arise in applying eco-
logical species richness estimators to T-cell repertoires also
confound the measurement of the extent of dispersion or
similarity between repertoires, and ecological indices should
be used with caution when analysing TCR repertoires.9. Non-parametric abundance based species
richness estimators
One of the most commonly used estimators is Chao1 [68] or
its bias-corrected form (Chao1-bc) [69]. These estimators have
been used to estimate TCR diversity in mice [70], and humans
[71], making use of an amendment to the estimator [72] that
takes account of the maximum upper bound of diversity.
The abundance-based coverage estimator (ACE) [73],
which has been suggested as best practice [58] and is com-
monly used in ecology, has been used to estimate repertoire
diversity in transgenic mice in the contexts of T-cell differen-
tiation [64], and TCR specificity and self-recognition [63,74].
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Figure 3. Performance of species richness estimators. (a,c) The Chao1bc (blue), Chao2 (orange), ACE (grey), Bootstrap (green) and Good-Turing (black) estimators are
applied to in silico random subsamples of observed data. Examples for HTLV-1 and microbial data are shown. Estimates systematically increase with sample size.
Chao2 estimates are calculated by randomly dividing each subsample into four in silico replicates. We observe the same bias with sample size where subsamples
were divided into two and three in silico replicates (data not shown). (b,d ) DivE (red) is applied to same subsamples as the other estimators. Performance of DivE
was evaluated by comparing the error of estimates (Sˆobs), to the (known) number of species Sobs in the full observed data ( purple line) and by comparing estimates
as a function of sample size. In all datasets, DivE accurately estimates the species richness of the full observed data from subsamples of that data and is unbiased by
sample size.
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ability that uniform sampling would produce the observed
frequency distribution.
Weinstein et al. [30] used a capture–recapture approach to
estimate the size of the antibody repertoire in zebrafish, and
this approach was extended in Glanville et al. [31] to estimate
antibody diversity in humans. The latter study also used a
technique that allows sequencing of reads long enough to span
all three CDR regions, which would allow more direct data
on T-cell repertoires to be collected. No validation of the
capture–recapture method was performed in either study.
Non-parametric abundance-based species richness estima-
tors have been validated using ecological populations that
have been extensively sampled and where approximate species
richness is assumed to be known [75]. However, the accuracy of
these ecological estimators has been questioned in immunologi-
cal populations. We recently compared the performance of
widely used non-parametric species richness estimators (the
Chao1bc [69], ACE [73], Bootstrap [76] and Good-Turing [77]
estimators) from population ecologywhen applied to immuno-
logical and microbiological systems [53]. We considered three
distinct sets of data: the clonal distribution of cells naturally
infected with human T-lymphotropic virus type-1 (HTLV-1),
operational taxonomic units (OTUs) of Bifidobacteria in thegastrointestinal tract of infants, and T-cell receptor repertoires.
In the case of HTLV-1, a ‘species’ is a clone, defined as a popu-
lation of infected cells that share a genomic site of proviral
integration.
For each set of data, we found that all estimators were
biased by sample size (figures 3 and 4). This is problematic
as estimates of species richness would increase if, for example,
greater blood volumes were drawn or technique sensitivity
was improved. Furthermore, there was strong evidence that
the estimators underestimated diversity. Firstly, the estimators
frequently produced estimates from subsamples that were
lower than the diversity of the full observed sample. Secondly,
in almost all cases, only a small number of unseen ‘species’ was
predicted in addition to those observed. Such estimates are
implausible in the HTLV-1 and T-cell repertoire datasets
where there is such a vast potential diversity.10. Non-parametric incidence-based species
richness estimators
The incidence-based coverage estimator [78] was used to esti-
mate the diversity of regulatory T cells in transgenic mice
[64], although no validation of this estimator was performed.
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Figure 4. Comparison of estimators: effect of sample size on estimated HTLV-1 diversity. Gradients measuring increase in estimated HTLV-1 clonal diversity against
increase in sample size. Gradients for each estimator were calculated by linear regression. All estimators except DivE show large gradients that are significantly
positive, indicating a bias with sample size. ***p, 0.0001; two-tailed binomial test (n ¼ 14).
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Chao2 estimator [79], resulting in an estimate of 108 clonotypes.
The Chao2 estimator makes use of incidence (i.e. presence or
absence) data, as opposed to abundance data, across different
replicates. The estimator therefore provides a method of avoid-
ing the distorted abundances due to PCR amplification
mentioned above.
To validate their approach, the authors created an in silico
Zipf distribution of clonotype frequencies from which to
sample. They took random samples of varying sizes and
found that the estimated diversity accurately estimated the
number of clonotypes in their in silico distribution. Although
indirect and using only one in silico distribution, this vali-
dation suggests that their method holds promise. However,
we have applied Chao2 to HTLV-1 and microbial OTU
data, and we again observed a bias with sample size, as
seen with the other non-parametric estimators we tested
(figures 3 and 4).11. Parametric species richness estimators
Robins et al. [47] frequently observed asmany as approximately
105 TCR clonotypes using single-molecule DNA sequencing,
and employed a method originally devised by Efron & Thisted
[80] and amended in Ionita-Laza et al. [81] to estimate a periph-
eral blood diversityof 3 to 4  106 clonotypes, including 1  106
antigen-experienced T-cell clonotypes, where the latter is
approximately one order of magnitude higher than estima-
ted previously [36]. Their method assumes that individual
T-cell clonotypes enter the sample according to a Poisson
process with clonotype-specific rates, which are inferred from
the observed clonotype abundances. The method predicts
the number of new sequences that would be observed in a
subsequent sample. Hence their method does not merely pro-
vide an estimate of TCR diversity, but also the relationship
between sample size and diversity. Therefore, the authors
were able to validate their method. While this validation was
direct, in that observation was compared with the predic-
ted number of additional clonotypes, it was limited to only a
single additional sample.Several recent studies have made use of the class of Poisson
abundance models (PAMs). Sepu´lveda et al. [59] noted that
species frequency data come from a multivariate hypergeo-
metric distribution (i.e. a multinomial distribution where
samples are taken without replacement). Because the size of
a sample is dwarfed by the size of the total population (and
therefore sampling does not drastically alter clonotype relative
abundances), these authors approximated the multivariate
hypergeometric distribution using a Poisson distribution.
Incorporation of a varying sampling rate for clonotypes of
varying frequencies leads to the class of PAMs [41,82]. They
applied their method to previously published data on mice
with different phenotypes, and evaluated the consistency of
their method by excluding clonotypes above successively
higher cut-off frequencies. Worryingly, there was wide vari-
ation in diversity estimates across all phenotypes depending
on the specific PAM used. Rempala et al. [41] focused on one
such model, the bivariate Poisson-lognormal distribution,
and concluded that under-sampling in their repertoire datasets
is more severe (and thus the population is more diverse) than
would be estimated using the Good-Turing estimator [77].
Other extensions of the class of PAMs have been developed
[41,82] that estimate the similarity between populations in
the presence of unseen clonotypes.
Using a compound Poisson process model used originally
to estimate gene capture diversity [83], Wang et al. [39] esti-
mated TCR diversity in the context of T-cell fate and
differentiation. This method can also model the relationship
between the number of clonotypes and the number of T
cells. They estimated approximately 106 unique TCRa and
TCRb CDR3 nucleotide sequences, approximately one third
of that predicted by Arstila et al. [36]. Their method was vali-
dated previously in the context of gene capture diversity [83]
using in silico distributions, choosing lognormal, exponential
and gamma distributions of varying diversities. It is unclear
how this validation translates to T-cell immunology.
In addition to the capture–recapture approach used in
Weinstein et al. [30], Klarenbeek et al. [37] fitted multiple Pois-
son mixture models to HTS data to estimate b-chain diversity
in the CD4þ and CD8þ T-cell compartments. Extending the
distribution fitted to the observed data to model the
number of unseen clonotypes, the authors estimated that
generate rarefaction data(a)
(b)
take successively smaller nested subsamples of rarefaction data
fit candidate models to rarefaction subsamples by least-squares regression
evaluate model performance using DivE criteria
extrapolate best-performing models to chosen population size
the geometric mean of these models gives DivE diversity estimate
model A: performs poorly
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o
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Figure 5. Outline of DivE species richness estimator. (a) Flow chart describing the process to calculate the DivE species richness estimate. (b) Full rarefaction curves
shown in black and nested rarefaction subsample shown in orange. Data are denoted by circles, model fits by solid lines. Models are scored according to the
following criteria: (i) discrepancy—mean percentage error between data points and model prediction; (ii) accuracy—error between full sample species richness
( purple cross) and estimated species richness from subsample; (iii) similarity—area between subsample fit (orange) and full data fit (black) and (iv) plausibility—
we require that S0(x)  0 and S00(x)  0. Model A performs poorly as criteria (ii) and (iii) are not satisfied. Model B performs well as all criteria are satisfied.
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clones and is far more diverse than thought previously [36]
(only 2 and 3–10 times less diverse than the naive repertoire
in CD4þ and CD8þ T-cell compartments, respectively). Their
estimates are also remarkable in that they predict that more
than 90% of memory clonotypes are relatively small.
Power laws have been used to model the form of the T-cell
repertoire [84,85]. An advantage of thismethod is that the fitted
parameters are relatively easy to interpret. It can be shown that
one parameter quantifies the proportion of the repertoire occu-
pied by clonotypes of a single T cell, and the other provides a
measure of dispersion. Power law characterizations of the
T-cell repertoire could be extended to estimate the number of
unseen clonotypes in a similar manner to Klarenbeek et al.
[37] by extending the modelled distribution.
Parametric approaches are often evaluated using goodness
of fit to the observed data, for example using x2-tests or
Akaike’s information criterion (AICc) [30,59,86,87]. While
these methods are useful for comparative purposes, they do
not validate the resulting model’s accuracy. A major limitation
of all parametric approaches is that the estimated diversity is
dependent on the assumed form of the clonotype distribution.12. A new approach to T-cell receptor diversity
estimation: DivE
We developed an estimator named DivE [53] which uses
rarefaction curves (figure 5). Similar to a species accumulation
curve, an individual-based rarefaction curve is createdbycumu-
lating the number of species as the number of observed
individuals (e.g. a T cell) increases, in a single resample. Species
counts are averaged over multiple resamples of the data to
obtain the expected number of species as a function of the
number of individuals. Sample-based rarefaction curves plot
the expected number of species against the number of samples.
DivE involves fittingmultiple simplemathematical models,
many of which are well known in ecological studies [88,89], to
rarefaction curves, and to nested subsamples of these curves.
Novel criteria are then used to determine the most appropriate
model; as well as assessing the quality of fit to seen data these
criteria also assess the quality of fit to unseen data, i.e. how
well a given model can predict the full dataset from random
subsets thereof. The best-performing models are then aggre-
gated and extrapolated to a user-specified population size to
produce the diversity estimate (figure 5).
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We measured the extent to which DivE could: (i) estimate the
diversity of the observed dataset from subsamples; (ii) estimate
from a single dataset the diversity of additional independent
HTLV-1 data, obtained using separate blood samples taken in
immediate succession and (iii) provide consistent estimates
given samples of unequal size. In each validation, the estimator
performed better than the non-parametric abundance-based
estimators we tested (figure 3). We believe the principal
reason that DivE performs well is that candidate models are
selected on their ability to consistently predict additional rare-
faction data. The additional data (i.e. the full rarefaction curve)
have no influence on fitted parameter values, and so DivE not
only assesses goodness of fit but also evaluates the accuracy of
the model. DivE has been provided as an R package [90], avail-
able at http://cran.r-project.org/web/packages/DivE/index.
html [91].
Accurate extrapolation of rarefaction curves assumes that
the sampled population is representative of the whole popu-
lation to be extrapolated to [60,92,93]. This is a reasonable
assumption in the case of T-cell sampling in the blood, i.e.
T cells sampled in one blood draw are likely to be represen-
tative of all T cells in the peripheral blood. However, this is
a poor assumption when trying to infer the TCR diversity
in the whole body as T cells sampled in the blood may not
be representative of T cells in lymphoid tissue, etc. The diffi-
culty of inferring total population diversity from estimates in
the blood is not unique to DivE and will adversely affect the
accuracy of all estimators.
An alternative approach to rarefaction curve extrapolation
that is based on a rigorous statistical footing has recently been
developed [94–96]. However, to estimate the rarefaction
curve, this method requires an input of species richness
(usually provided by ACE or Chao1), which is the quantity
we seek to estimate. Furthermore, the authors of these
papers caution that this method is not suitable for extrapol-
ation beyond two- or threefold.
We summarize the advantages and disadvantages of
different diversity estimation methods in T-cell repertoire
analysis in table 1.13. Discussion
To estimate repertoire diversity it is essential to obtain
unbiased data, with absolute counts of TCR clonotypes. If
unbiased absolute count data are not available, neither rela-
tive abundances nor the degree of repetition of observations
are credible, and so diversity estimators should not be
applied. While Chao2 does not require abundance data, we
have found that this estimator too is biased by sample size
in immunological and microbiological data (figure 3).
We also caution against estimating diversity using severely
under-sampled data, whether due to limited sequencing depth
or low blood volume. To quantify ‘under-sampling’, we pre-
viously defined a parameter based on the curvature of the
observed rarefaction curve (see [53] for further details).A linear rarefaction curve implies an implausible constant
rate of species accumulation. As sampling depth increases,
the rate of species accumulation should decrease as previously
encountered species are repeatedly observed. Abundance-
based estimators should not be applied when the rarefaction
curve is close to linear.
Recent advances in HTS combined with DNA barcoding
mean that unbiased absolute count data is now increasingly
available. However, because of the enormous potential diver-
sity of the TCR repertoire and the limited amount of blood
that can be drawn from a donor at any given time, there will
almost certainly be unseen TCR clonotypes regardless of the
precision of data collection. Therefore, estimators of diversity
must be employed. Existing parametric estimators suffer from
the requirement of an a priori form of the species frequency dis-
tribution. Furthermore, each non-parametric estimator we have
tested, either abundance- or incidence-based, was significantly
biased by sample size.
Absolute count data allow important simplifying assump-
tions to be made about the relationship between the observed
data and the underlying T-cell repertoire, namely that individ-
ual T cells have been sampled independently, randomly and
with equal detection probabilities. These assumptions in turn
allow the extrapolation of models fitted to individual-based
rarefaction curves. The question of which model to fit, how-
ever, is non-trivial. DivE selects which models are most
appropriate based on their ability to faithfully reproduce all
observed rarefaction data from subsamples, providing a
degree of robustness that we have not observed with classical
non-parametric estimators. Crucially, the form of the model
chosen depends on the data, and so DivE does not require a
priori assumptions regarding the form of the clonotype fre-
quency distribution, or regarding the relationship between
the number of T cells and the number of TCR clonotypes.
We have validated DivE across three independent immuno-
logical andmicrobiological systems. In all systems, the estimator
was accurate, and considerablymore so than the non-parametric
estimatorsweexamined.Webelieve that this estimatorwill bean
important tool to estimate T-cell repertoire diversity.Ethics. HTLV-1 and microbial data were obtained as previously
described [53]. Ethics approval was given by the UK National
Research Ethics Service (NRES references 09/H0606/106 and 05/
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jects provided full written informed consent.
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